Lucinda Billingham
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Surgery top 5%
- Molecular Biology top 10%
- Epidemiology top 5%
- Co-authors
- Keith R. AbramsNeil StevenStirling BryanM.H. CullenDaniel ReaRichard T. BryanD. Michael A. WallacePhilip J. Johnson
- Topics
- Lung Cancer Treatments and Mutations (23 papers)Statistical Methods in Clinical Trials (21 papers)Health Systems, Economic Evaluations, Quality of Life (17 papers)
- Partner nations
- United KingdomUnited StatesNetherlands
In The Last Decade
Lucinda Billingham
131 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 152
- Oncology 2.1k
- Pulmonary and Respiratory Medicine 1.2k
- Surgery 941
- Molecular Biology 861
- Epidemiology 736
Countries citing papers authored by Lucinda Billingham
This map shows the geographic impact of Lucinda Billingham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucinda Billingham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucinda Billingham more than expected).
Fields of papers citing papers by Lucinda Billingham
This network shows the impact of papers produced by Lucinda Billingham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucinda Billingham. The network helps show where Lucinda Billingham may publish in the future.
Co-authorship network of co-authors of Lucinda Billingham
This figure shows the co-authorship network connecting the top 25 collaborators of Lucinda Billingham. A scholar is included among the top collaborators of Lucinda Billingham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucinda Billingham. Lucinda Billingham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 5 | |
| 6 | 1 | |
| 7 | 4 | |
| 8 | 9 | |
| 9 | 1 | |
| 10 | 21 | |
| 11 | 15 | |
| 12 | 17 | |
| 13 | 21 | |
| 14 | 15 | |
| 15 | 5 | |
| 16 | 0 | |
| 17 | 39 | |
| 18 | Mitomycin,Ifosfamide and cisplatin in unresectable non-small cell lung cancer: Effects on survival and quality of life | 6 |
| 19 | Methods for the analysis of quality-of-life and survival data in health technology assessment. | 248 |
| 20 | Quality assurance of CD34+ cell estimation in leucapheresis products. | 22 |
About Lucinda Billingham
Lucinda Billingham is a scholar working on Statistics and Probability, Oncology and Cancer Research, having authored 138 papers that have together received 5.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (23 papers), Statistical Methods in Clinical Trials (21 papers) and Health Systems, Economic Evaluations, Quality of Life (17 papers). The work is most often cited by research in Oncology (2.1k citations), Pulmonary and Respiratory Medicine (1.2k citations) and Cancer Research (512 citations). Lucinda Billingham has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include Keith R. Abrams, Neil Steven, Stirling Bryan, M.H. Cullen, Daniel Rea, Richard T. Bryan, D. Michael A. Wallace, Philip J. Johnson, Andrea Burton and K Malottki. Their work appears in journals such as New England Journal of Medicine, The Lancet and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.